| 1 |
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006 May;7(5):392-401.
|
| 2 |
Armodafinil FDA Label
|
| 3 |
Stereotactic injection of DTI-015 into recurrent malignant gliomas: phase I/II trial. Neoplasia. 2003 Jan-Feb;5(1):9-16.
|
| 4 |
Granisetron FDA Label
|
| 5 |
Modafinil FDA Label
|
| 6 |
Ondansetron FDA Label
|
| 7 |
Temozolomide FDA Label
|
| 8 |
ClinicalTrials.gov (NCT00589875) Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02). U.S. National Institutes of Health.
|
| 9 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 10 |
Clinical pipeline report, company report or official report of Activartis Biotech.
|
| 11 |
ClinicalTrials.gov (NCT01454596) CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII. U.S. National Institutes of Health.
|
| 12 |
ClinicalTrials.gov (NCT02617134) CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor
|
| 13 |
ClinicalTrials.gov (NCT02575261) CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients
|
| 14 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 15 |
ClinicalTrials.gov (NCT04541225) Phase 1/2 Dose Escalation, Safety, Pharmacokinetics, and Efficacy Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors. U.S.National Institutes of Health.
|
| 16 |
ClinicalTrials.gov (NCT05218408) A Phase I/IIa Open Label Multicenter, Non-Randomized, Trial to Assess the Safety and Efficacy of CYNK-001in Combination With Recombinant Human Interleukin-2 in Adults With Recurrent Resection Eligible IDH1 Wild-type Glioblastoma. U.S.National Institutes of Health.
|
| 17 |
ClinicalTrials.gov (NCT03299309) PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma (PRiME). U.S. National Institutes of Health.
|
| 18 |
Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015).Expert Opin Ther Pat. 2017 Jun;27(6):657-666.
|
| 19 |
Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas.Cancer Lett. 2015 Mar 28;358(2):220-231. doi: 10.1016/j.canlet.2014.12.044. Epub 2014 Dec 24.
|
| 20 |
Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.Neuropeptides. 2010 Apr;44(2):177-85. doi: 10.1016/j.npep.2009.12.009. Epub 2010 Jan 18.
|
| 21 |
Bmi-1 promotes glioma angiogenesis by activating NF-B signaling.PLoS One. 2013;8(1):e55527. doi: 10.1371/journal.pone.0055527. Epub 2013 Jan 31.
|
| 22 |
Differential activation of catalase expression and activity by PPAR agonists: implications for astrocyte protection in anti-glioma therapy.Redox Biol. 2013 Jan 26;1(1):70-9. doi: 10.1016/j.redox.2012.12.006. eCollection 2013.
|
| 23 |
Low-frequency ultrasound irradiation increases blood-tumor barrier permeability by transcellular pathway in a rat glioma model.J Mol Neurosci. 2012 Sep;48(1):281-90. doi: 10.1007/s12031-012-9770-0. Epub 2012 Apr 20.
|
| 24 |
Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.Cancer Immunol Immunother. 2008 Jan;57(1):123-31. doi: 10.1007/s00262-007-0336-x. Epub 2007 May 24.
|
| 25 |
Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma.Cancer Res. 2002 May 1;62(9):2592-9.
|
| 26 |
Expression of voltage-gated chloride channels in human glioma cells.J Neurosci. 2003 Jul 2;23(13):5572-82. doi: 10.1523/JNEUROSCI.23-13-05572.2003.
|
| 27 |
The role of thrombin in gliomas.J Thromb Haemost. 2005 Sep;3(9):1917-23. doi: 10.1111/j.1538-7836.2005.01446.x. Epub 2005 Jun 24.
|
| 28 |
Promoter hypermethylation is not the major mechanism for inactivation of the FBXW7 beta-form in human gliomas.Genes Genet Syst. 2008 Aug;83(4):347-52. doi: 10.1266/ggs.83.347.
|
| 29 |
Heavy chain ferritin siRNA delivered by cationic liposomes increases sensitivity of cancer cells to chemotherapeutic agents.Cancer Res. 2011 Mar 15;71(6):2240-9. doi: 10.1158/0008-5472.CAN-10-1375. Epub 2011 Mar 8.
|
| 30 |
Human alloreactive CTL interactions with gliomas and with those having upregulated HLA expression from exogenous IFN-gamma or IFN-gamma gene modification.J Interferon Cytokine Res. 2003 Jul;23(7):379-93. doi: 10.1089/107999003322226032.
|
| 31 |
Widely metastatic IDH1-mutant glioblastoma with oligodendroglial features and atypical molecular findings: a case report and review of current challenges in molecular diagnostics.Diagn Pathol. 2019 Feb 9;14(1):16. doi: 10.1186/s13000-019-0793-5.
|
| 32 |
A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma.Anticancer Drugs. 2008 Feb;19(2):133-42. doi: 10.1097/CAD.0b013e3282f24017.
|
| 33 |
Galectin-3 in preneoplastic lesions of glioma.J Neurooncol. 2013 Jan;111(2):123-32. doi: 10.1007/s11060-012-1005-2. Epub 2012 Nov 23.
|
| 34 |
MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism.Nat Genet. 2016 Mar;48(3):273-82. doi: 10.1038/ng.3500. Epub 2016 Feb 1.
|
| 35 |
Glioma migration can be blocked by nontoxic inhibitors of myosin II.Cancer Res. 1999 May 1;59(9):2076-82.
|
| 36 |
Deep multiomics profiling of brain tumors identifies signaling networks downstream of cancer driver genes.Nat Commun. 2019 Aug 16;10(1):3718. doi: 10.1038/s41467-019-11661-4.
|
| 37 |
The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma.Nat Genet. 2014 May;46(5):444-450. doi: 10.1038/ng.2938. Epub 2014 Apr 6.
|
| 38 |
Combination of lentivirus-mediated silencing of PPM1D and temozolomide chemotherapy eradicates malignant glioma through cell apoptosis and cell cycle arrest.Oncol Rep. 2016 Nov;36(5):2544-2552. doi: 10.3892/or.2016.5089. Epub 2016 Sep 14.
|
| 39 |
PI3K activation in neural stem cells drives tumorigenesis which can be ameliorated by targeting the cAMP response element binding protein.Neuro Oncol. 2018 Sep 3;20(10):1344-1355. doi: 10.1093/neuonc/noy068.
|
| 40 |
Novel GOPC(FIG)-ROS1 fusion in a pediatric high-grade glioma survivor.J Neurosurg Pediatr. 2017 Jul;20(1):51-55. doi: 10.3171/2017.2.PEDS16679. Epub 2017 Apr 7.
|
| 41 |
Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas.J Exp Clin Cancer Res. 2012 Oct 11;31(1):85. doi: 10.1186/1756-9966-31-85.
|
| 42 |
Ultrasound-sensitive siRNA-loaded nanobubbles formed by hetero-assembly of polymeric micelles and liposomes and their therapeutic effect in gliomas.Biomaterials. 2013 Jun;34(18):4532-43. doi: 10.1016/j.biomaterials.2013.02.067. Epub 2013 Mar 19.
|
| 43 |
Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy.Mol Cell Biochem. 2015 Jan;399(1-2):279-89. doi: 10.1007/s11010-014-2254-5. Epub 2014 Nov 20.
|
| 44 |
Alteration of striatal dopaminergic function induced by glioma development: a microdialysis and immunohistological study in the rat striatum.Neurosci Lett. 2004 Jan 9;354(2):131-4. doi: 10.1016/j.neulet.2003.10.005.
|
| 45 |
The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer.Clin Immunol. 2006 Nov;121(2):144-58. doi: 10.1016/j.clim.2006.06.010. Epub 2006 Aug 10.
|
| 46 |
Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma.Stem Cells Transl Med. 2014 Feb;3(2):172-82. doi: 10.5966/sctm.2013-0132. Epub 2014 Jan 16.
|
| 47 |
DNA topoisomerase II-alpha as a proliferation marker in human gliomas: correlation with PCNA expression and patient survival.Clin Neuropathol. 2008 Mar-Apr;27(2):83-90. doi: 10.5414/npp27083.
|
| 48 |
Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):1970-82. doi: 10.1158/1078-0432.CCR-05-2797.
|
| 49 |
Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression.Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3421-6. doi: 10.1073/pnas.1414573112. Epub 2015 Mar 3.
|
| 50 |
TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF(V600E)/TERT promoter double-mutated glioma.Acta Neuropathol Commun. 2019 Aug 7;7(1):128. doi: 10.1186/s40478-019-0775-6.
|
| 51 |
Adenovirus-mediated delivery of bFGF small interfering RNA reduces STAT3 phosphorylation and induces the depolarization of mitochondria and apoptosis in glioma cells U251.J Exp Clin Cancer Res. 2011 Sep 9;30(1):80. doi: 10.1186/1756-9966-30-80.
|
| 52 |
Adjuvant therapeutic potential of tonabersat in the standard treatment of glioblastoma: Apreclinical F98 glioblastoma rat model study.PLoS One. 2019 Oct 21;14(10):e0224130. doi: 10.1371/journal.pone.0224130. eCollection 2019.
|
| 53 |
miR-361-5p inhibits glioma migration and invasion by targeting SND1.Onco Targets Ther. 2018 Aug 28;11:5239-5252. doi: 10.2147/OTT.S171539. eCollection 2018.
|
| 54 |
Evaluation of human glioma using in-vivo proton magnetic resonance spectroscopy combined with expression of cyclooxygenase-2: a preliminary clinical trial.Neuroreport. 2017 May 3;28(7):414-420. doi: 10.1097/WNR.0000000000000771.
|
| 55 |
Selective decrease of SN1(SNAT3) mRNA expression in human and rat glioma cells adapted to grow in acidic medium. Neurochem Int. 2006 May-Jun;48(6-7):547-52.
|
| 56 |
Herpes simplex virus 1 recombinant virions exhibiting the amino terminal fragment of urokinase-type plasminogen activator can enter cells via the cognate receptor.Gene Ther. 2006 Apr;13(7):621-9. doi: 10.1038/sj.gt.3302685.
|
| 57 |
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations.Nat Genet. 2014 May;46(5):451-6. doi: 10.1038/ng.2936. Epub 2014 Apr 6.
|
| 58 |
Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study.NMR Biomed. 2008 Nov;21(10):1043-56. doi: 10.1002/nbm.1278.
|
| 59 |
RAF expression in human astrocytic tumors.Int J Mol Med. 2009 Jan;23(1):17-31.
|
| 60 |
Increased expression of schwannoma-derived growth factor (SDGF) mRNA in rat tumor cells: involvement of SDGF in the growth promotion of rat gliomas.Int J Cancer. 1996 May 3;66(3):352-7. doi: 10.1002/(SICI)1097-0215(19960503)66:3<352::AID-IJC15>3.0.CO;2-D.
|
| 61 |
Lack of correlation between ATM protein expression and tumour cell radiosensitivity.Int J Radiat Biol. 1998 Aug;74(2):217-24. doi: 10.1080/095530098141591.
|
| 62 |
The sodium pump 1 subunit regulates bufalin sensitivity of human glioblastoma cells through the p53 signaling pathway.Cell Biol Toxicol. 2019 Dec;35(6):521-539. doi: 10.1007/s10565-019-09462-y. Epub 2019 Feb 9.
|
| 63 |
Aurora kinase B/C inhibition impairs malignant glioma growth in vivo.J Neurooncol. 2012 Jul;108(3):349-60. doi: 10.1007/s11060-012-0835-2. Epub 2012 Mar 1.
|
| 64 |
Intracranial stereotaxic cannulation for development of orthotopic glioblastoma allograft in Sprague-Dawley rats and histoimmunopathological characterization of the brain tumor.Neurochem Res. 2007 Dec;32(12):2235-42. doi: 10.1007/s11064-007-9450-6. Epub 2007 Aug 15.
|
| 65 |
Targeting CAIX with [(64)Cu]XYIMSR-06 Small Molecular Radiotracer Enables Noninvasive PET Imaging of Malignant Glioma in U87 MG Tumor Cell Xenograft Mice.Mol Pharm. 2019 Apr 1;16(4):1532-1540. doi: 10.1021/acs.molpharmaceut.8b01210. Epub 2019 Mar 12.
|
| 66 |
Expression and activity of the calcitonin receptor family in a sample of primary human high-grade gliomas.BMC Cancer. 2019 Feb 18;19(1):157. doi: 10.1186/s12885-019-5369-y.
|
| 67 |
Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells.Int J Oncol. 2004 Jul;25(1):57-63.
|
| 68 |
CBX7 is a glioma prognostic marker and induces G1/S arrest via the silencing of CCNE1. Oncotarget. 2017 Apr 18;8(16):26637-26647.
|
| 69 |
Influence of multiple delays in brain tumor and immune system interaction with T11 target structure as a potent stimulator.Math Biosci. 2018 Aug;302:116-130. doi: 10.1016/j.mbs.2018.06.001. Epub 2018 Jun 15.
|
| 70 |
Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1-transfected tumor cells.Cancer Gene Ther. 1999 Jan-Feb;6(1):37-44. doi: 10.1038/sj.cgt.7700023.
|
| 71 |
Adenoviral p16/CDKN2 gene transfer to malignant glioma: role of p16 in growth, invasion, and senescence.Oncol Rep. 2003 Sep-Oct;10(5):1121-6.
|
| 72 |
Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma.Oncogenesis. 2017 May 15;6(5):e336. doi: 10.1038/oncsis.2017.33.
|
| 73 |
Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target.Int J Cancer. 2003 May 10;104(6):752-7. doi: 10.1002/ijc.11023.
|
| 74 |
Antiangiogenic drugs synergize with a membrane macrophage colony-stimulating factor-based tumor vaccine to therapeutically treat rats with an established malignant intracranial glioma.J Immunol. 2005 Mar 1;174(5):2533-43. doi: 10.4049/jimmunol.174.5.2533.
|
| 75 |
Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells.J Virol. 2007 Apr;81(8):4186-98. doi: 10.1128/JVI.02601-06. Epub 2007 Feb 7.
|
| 76 |
Chemokine receptor CXCR3 promotes growth of glioma.Carcinogenesis. 2011 Feb;32(2):129-37. doi: 10.1093/carcin/bgq224. Epub 2010 Nov 3.
|
| 77 |
Towards a complete picture of splice variants of the gene for 25-hydroxyvitamin D31alpha-hydroxylase in brain and skin cancer.J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):527-32. doi: 10.1016/j.jsbmb.2004.03.062.
|
| 78 |
Inhibition of experimental rat glioma growth by decorin gene transfer is associated with decreased microglial infiltration.J Neuroimmunol. 1999 Sep 1;99(1):13-8. doi: 10.1016/s0165-5728(99)00062-4.
|
| 79 |
Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells.J Neurooncol. 2017 Jun;133(2):297-307. doi: 10.1007/s11060-017-2457-1. Epub 2017 May 29.
|
| 80 |
P68 RNA helicase promotes invasion of glioma cells through negatively regulating DUSP5.Cancer Sci. 2019 Jan;110(1):107-117. doi: 10.1111/cas.13858. Epub 2018 Dec 3.
|
| 81 |
Inhibition of elongation factor-2 kinase augments the antitumor activity of Temozolomide against glioma.PLoS One. 2013 Nov 26;8(11):e81345. doi: 10.1371/journal.pone.0081345. eCollection 2013.
|
| 82 |
Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signaling.Cancer Sci. 2018 Dec;109(12):3874-3882. doi: 10.1111/cas.13826. Epub 2018 Nov 5.
|
| 83 |
EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis.J Cell Physiol. 2018 Nov;233(11):8526-8537. doi: 10.1002/jcp.26792. Epub 2018 Jun 19.
|
| 84 |
GCN2 is essential for CD8(+) T cell survival and function in murine models of malignant glioma.Cancer Immunol Immunother. 2020 Jan;69(1):81-94. doi: 10.1007/s00262-019-02441-6. Epub 2019 Dec 16.
|
| 85 |
Inhibition of eIF4F complex loading inhibits the survival of malignant glioma.Oncol Rep. 2018 Oct;40(4):2399-2407. doi: 10.3892/or.2018.6587. Epub 2018 Jul 20.
|
| 86 |
Targeting the erythropoietin receptor on glioma cells reduces tumour growth.Exp Cell Res. 2011 Oct 1;317(16):2321-32. doi: 10.1016/j.yexcr.2011.06.011. Epub 2011 Jun 30.
|
| 87 |
Replication-competent herpes simplex virus retargeted to HER2 as therapy for high-grade glioma.Mol Ther. 2012 May;20(5):994-1001. doi: 10.1038/mt.2012.22. Epub 2012 Feb 21.
|
| 88 |
High epiregulin expression in human U87 glioma cells relies on IRE1 and promotes autocrine growth through EGF receptor.BMC Cancer. 2013 Dec 13;13:597. doi: 10.1186/1471-2407-13-597.
|
| 89 |
Novel target for peptide-based imaging and treatment of brain tumors.Mol Cancer Ther. 2014 Apr;13(4):996-1007. doi: 10.1158/1535-7163.MCT-13-0684. Epub 2014 Feb 3.
|
| 90 |
CD95-mediated apoptosis of human glioma cells: modulation by epidermal growth factor receptor activity.Brain Pathol. 2002 Jan;12(1):12-20. doi: 10.1111/j.1750-3639.2002.tb00418.x.
|
| 91 |
FGFR1 Expression and Role in Migration in Low and High Grade Pediatric Gliomas.Front Oncol. 2019 Mar 13;9:103. doi: 10.3389/fonc.2019.00103. eCollection 2019.
|
| 92 |
MicroRNA-206 attenuates glioma cell proliferation, migration, and invasion by blocking the WNT/-catenin pathway via direct targeting of Frizzled 7 mRNA.Am J Transl Res. 2019 Jul 15;11(7):4584-4601. eCollection 2019.
|
| 93 |
Characterization of gastrin-induced cytostatic effect on cell proliferation in experimental malignant gliomas.Neurosurgery. 2003 Apr;52(4):881-90; discussion 890-1. doi: 10.1227/01.neu.0000053366.00088.80.
|
| 94 |
Egr-1 and RNA POL II facilitate glioma cell GDNF transcription induced by histone hyperacetylation in promoter II.Oncotarget. 2017 Jul 11;8(28):45105-45116. doi: 10.18632/oncotarget.15126.
|
| 95 |
In vitro neurosphere formation correlates with poor survival in glioma.IUBMB Life. 2019 Feb;71(2):244-253. doi: 10.1002/iub.1964. Epub 2018 Nov 4.
|
| 96 |
Connexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy.Neuro Oncol. 2015 Mar;17(3):392-406. doi: 10.1093/neuonc/nou215. Epub 2014 Aug 25.
|
| 97 |
Underediting of glutamate receptor GluR-B mRNA in malignant gliomas.Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14687-92. doi: 10.1073/pnas.251531398. Epub 2001 Nov 20.
|
| 98 |
Targeting metabotropic glutamate receptors in the treatment of primary brain tumors.Curr Opin Pharmacol. 2018 Feb;38:59-64. doi: 10.1016/j.coph.2018.02.005. Epub 2018 Mar 8.
|
| 99 |
In vitro drug response and molecular markers associated with drug resistance in malignant gliomas. Clin Cancer Res. 2006 Aug 1;12(15):4523-32. doi: 10.1158/1078-0432.CCR-05-1830.
|
| 100 |
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.Nature. 2000 May 18;405(6784):354-60. doi: 10.1038/35012626.
|
| 101 |
HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF- pathways.Oncotarget. 2015 Sep 29;6(29):27778-93. doi: 10.18632/oncotarget.4813.
|
| 102 |
Ras-Induced miR-146a and 193a Target Jmjd6 to Regulate Melanoma Progression.Front Genet. 2018 Dec 18;9:675. doi: 10.3389/fgene.2018.00675. eCollection 2018.
|
| 103 |
Antitumorigenic effect of interferon- by inhibition of undifferentiated glioblastoma cells.Int J Oncol. 2015 Nov;47(5):1647-54. doi: 10.3892/ijo.2015.3165. Epub 2015 Sep 14.
|
| 104 |
Cintredekin besudotox in treatment of malignant glioma.Expert Opin Biol Ther. 2008 Jun;8(6):805-12. doi: 10.1517/14712598.8.6.805.
|
| 105 |
Induction of cytotoxic T lymphocytes specific to malignant glioma using T2 cells pulsed with HLA-A2-restricted interleukin-13 receptor alpha 2 peptide in vitro.Acta Biochim Biophys Sin (Shanghai). 2007 Sep;39(9):641-8. doi: 10.1111/j.1745-7270.2007.00331.x.
|
| 106 |
Decreasing expression of the interleukin-13 receptor IL-13Ralpha2 in treated recurrent malignant gliomas.Neurol Med Chir (Tokyo). 2010;50(8):617-21. doi: 10.2176/nmc.50.617.
|
| 107 |
Relative expression of mRNAS coding for glutaminase isoforms in CNS tissues and CNS tumors.Neurochem Res. 2008 May;33(5):808-13. doi: 10.1007/s11064-007-9507-6. Epub 2007 Oct 17.
|
| 108 |
Downregulation of KDM4A Suppresses the Survival of Glioma Cells by Promoting Autophagy.J Mol Neurosci. 2016 Oct;60(2):137-44. doi: 10.1007/s12031-016-0796-6. Epub 2016 Aug 11.
|
| 109 |
Ketohexokinase is involved in fructose utilization and promotes tumor progression in glioma.Biochem Biophys Res Commun. 2018 Sep 10;503(3):1298-1306. doi: 10.1016/j.bbrc.2018.07.040. Epub 2018 Jul 19.
|
| 110 |
LAMP-1 gene is overexpressed in high grade glioma.APMIS. 2018 Aug;126(8):657-662. doi: 10.1111/apm.12856. Epub 2018 Jun 19.
|
| 111 |
LIM and SH3 protein 1 induces glioma growth and invasion through PI3K/AKT signaling and epithelial-mesenchymal transition.Biomed Pharmacother. 2019 Aug;116:109013. doi: 10.1016/j.biopha.2019.109013. Epub 2019 May 27.
|
| 112 |
miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways.Int J Oncol. 2014 May;44(5):1571-80. doi: 10.3892/ijo.2014.2322. Epub 2014 Mar 5.
|
| 113 |
Adenovirus-mediated overexpression of Fas induces apoptosis of gliomas.Cancer Gene Ther. 2000 Feb;7(2):224-32. doi: 10.1038/sj.cgt.7700110.
|
| 114 |
Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action. Cell Death Differ. 2011 Jun;18(6):959-73. doi: 10.1038/cdd.2010.170. Epub 2011 Jan 14.
|
| 115 |
Tumor-specific activation of the C-JUN/MELK pathway regulates glioma stem cell growth in a p53-dependent manner.Stem Cells. 2013 May;31(5):870-81. doi: 10.1002/stem.1322.
|
| 116 |
Evaluation of biocompatibility and anti-glioma efficacy of doxorubicin and irinotecan drug-eluting bead suspensions in alginate.Clin Transl Oncol. 2012 Jan;14(1):50-9. doi: 10.1007/s12094-012-0761-y.
|
| 117 |
Downregulation of uPARAP mediates cytoskeletal rearrangements and decreases invasion and migration properties in glioma cells.J Neurooncol. 2011 Jun;103(2):267-76. doi: 10.1007/s11060-010-0398-z. Epub 2010 Sep 16.
|
| 118 |
Musashi1 enhances chemotherapy resistance of pediatric glioblastoma cells in vitro.Pediatr Res. 2020 Mar;87(4):669-676. doi: 10.1038/s41390-019-0628-9. Epub 2019 Nov 22.
|
| 119 |
HMGA1 expression in human gliomas and its correlation with tumor proliferation, invasion and angiogenesis.J Neurooncol. 2012 Feb;106(3):543-9. doi: 10.1007/s11060-011-0710-6. Epub 2011 Oct 8.
|
| 120 |
Overexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant glioma.J Neurooncol. 2017 May;132(3):409-417. doi: 10.1007/s11060-017-2401-4. Epub 2017 Mar 21.
|
| 121 |
Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2.Clin Cancer Res. 2007 May 1;13(9):2592-8. doi: 10.1158/1078-0432.CCR-06-2772.
|
| 122 |
Identification and functional validation of CDH11, PCSK6 and SH3GL3 as novel glioma invasion-associated candidate genes.Neuropathol Appl Neurobiol. 2012 Apr;38(2):201-12. doi: 10.1111/j.1365-2990.2011.01207.x.
|
| 123 |
Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma.Oncol Rep. 2014 Jul;32(1):250-60. doi: 10.3892/or.2014.3176. Epub 2014 May 15.
|
| 124 |
Clinicopathological significance of Polo-like kinase 1 (PLK1) expression in human malignant glioma.Acta Histochem. 2012 Sep;114(5):503-9. doi: 10.1016/j.acthis.2011.09.004. Epub 2011 Oct 13.
|
| 125 |
Lipoprotein lipase and phospholipid transfer protein overexpression in human glioma cells and their effect on cell growth, apoptosis, and migration.Acta Biochim Biophys Sin (Shanghai). 2017 Jan;49(1):62-73. doi: 10.1093/abbs/gmw117. Epub 2016 Nov 17.
|
| 126 |
Cyclophilin B supports Myc and mutant p53-dependent survival of glioblastoma multiforme cells.Cancer Res. 2014 Jan 15;74(2):484-96. doi: 10.1158/0008-5472.CAN-13-0771. Epub 2013 Nov 22.
|
| 127 |
PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma.Cancer Res. 2009 Apr 1;69(7):2870-7. doi: 10.1158/0008-5472.CAN-08-2760. Epub 2009 Mar 17.
|
| 128 |
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas.Nat Genet. 2013 Jun;45(6):602-12. doi: 10.1038/ng.2611. Epub 2013 Apr 14.
|
| 129 |
CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.Br J Cancer. 2017 Jun 27;117(1):102-112. doi: 10.1038/bjc.2017.157. Epub 2017 Jun 1.
|
| 130 |
Increased expression of a glutamine transporter SNAT3 is a marker of malignant gliomas. Neuroreport. 2004 Mar 22;15(4):575-8.
|
| 131 |
Ste20-like kinase is upregulated in glioma and induces glioma invasion.Neoplasma. 2018;65(2):185-191. doi: 10.4149/neo_2018_170318N193.
|
| 132 |
SET and MYND domain-containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity.Oncol Rep. 2015 Nov;34(5):2722-30. doi: 10.3892/or.2015.4239. Epub 2015 Sep 1.
|
| 133 |
Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth.Cancer Res. 2002 Feb 15;62(4):1205-12.
|
| 134 |
Modulation of P-glycoprotein function by sphingosine kinase-1 in brain endothelial cells.J Neurochem. 2007 Mar;100(5):1203-10. doi: 10.1111/j.1471-4159.2006.04295.x.
|
| 135 |
Association of Notch-1, osteopontin and stem-like cells in ENU-glioma malignant process.Oncotarget. 2018 Jul 31;9(59):31330-31341. doi: 10.18632/oncotarget.25808. eCollection 2018 Jul 31.
|
| 136 |
The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas. J Natl Cancer Inst. 2007 Apr 18;99(8):639-52. doi: 10.1093/jnci/djk135.
|
| 137 |
TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.J Exp Clin Cancer Res. 2017 Nov 6;36(1):155. doi: 10.1186/s13046-017-0619-9.
|
| 138 |
High incidence of TERT mutation in brain tumor cell lines.Brain Tumor Pathol. 2016 Jul;33(3):222-7. doi: 10.1007/s10014-016-0257-5. Epub 2016 Mar 9.
|
| 139 |
Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-2.Cell Cycle. 2016 Jul 2;15(13):1755-66. doi: 10.1080/15384101.2016.1186316. Epub 2016 May 10.
|
| 140 |
Plant thymidine kinase 1: a novel efficient suicide gene for malignant glioma therapy.Neuro Oncol. 2010 Jun;12(6):549-58. doi: 10.1093/neuonc/nop067. Epub 2010 Feb 13.
|
| 141 |
Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease.Acta Neuropathol Commun. 2019 May 15;7(1):75. doi: 10.1186/s40478-019-0727-1.
|
| 142 |
Telomerase reverse transcriptase promoter-driven expression of iodine pump genes for targeted radioiodine therapy of malignant glioma cells.Chin J Cancer. 2011 Aug;30(8):574-80. doi: 10.5732/cjc.010.10580.
|
| 143 |
TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway.Oncogene. 2015 Jan 29;34(5):600-10. doi: 10.1038/onc.2013.593. Epub 2014 Jan 27.
|
| 144 |
TRIM28 is overexpressed in glioma and associated with tumor progression. Onco Targets Ther. 2018 Oct 10;11:6447-6458.
|
| 145 |
TRPM7 channel inhibition mediates midazolam-induced proliferation loss in human malignant glioma.Tumour Biol. 2016 Nov;37(11):14721-14731. doi: 10.1007/s13277-016-5317-2. Epub 2016 Sep 14.
|
| 146 |
Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis.Dev Biol. 2007 May 15;305(2):599-614. doi: 10.1016/j.ydbio.2007.03.004. Epub 2007 Mar 12.
|
| 147 |
Prognostic impact of CD68 and kallikrein 6 in human glioma.Anticancer Res. 2009 Aug;29(8):3269-79.
|
| 148 |
Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders.J Lipid Res. 2019 Feb;60(2):312-317. doi: 10.1194/jlr.R089763. Epub 2018 Oct 4.
|
| 149 |
Gefitinib inhibits sodium phosphate co-transporter III isoform 1 in a model of human malignant glioma.Anticancer Res. 2014 Nov;34(11):6527-35.
|
| 150 |
Acyl-CoA synthetase VL3 knockdown inhibits human glioma cell proliferation and tumorigenicity.Cancer Res. 2009 Dec 15;69(24):9175-82. doi: 10.1158/0008-5472.CAN-08-4689.
|
| 151 |
A chimeric fusion protein of cytochrome CYP4B1 and green fluorescent protein for detection of pro-drug activating gene delivery and for gene therapy in malignant glioma.Adv Exp Med Biol. 1998;451:393-403. doi: 10.1007/978-1-4615-5357-1_61.
|
| 152 |
Gene Expression and Methylation Analyses Suggest DCTD as a Prognostic Factor in Malignant Glioma.Sci Rep. 2017 Sep 14;7(1):11568. doi: 10.1038/s41598-017-11962-y.
|
| 153 |
Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction.Int J Cancer. 2006 Nov 15;119(10):2330-8. doi: 10.1002/ijc.22108.
|
| 154 |
G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma.Nat Commun. 2019 Feb 26;10(1):943. doi: 10.1038/s41467-019-08905-8.
|
| 155 |
Genome-wide association study identifies five susceptibility loci for glioma.Nat Genet. 2009 Aug;41(8):899-904. doi: 10.1038/ng.407. Epub 2009 Jul 5.
|
| 156 |
PPIC, EMP3 and CHI3L1 Are Novel Prognostic Markers for High Grade Glioma.Int J Mol Sci. 2016 Oct 28;17(11):1808. doi: 10.3390/ijms17111808.
|
| 157 |
Interaction of brain fatty acid-binding protein with the polyunsaturated fatty acid environment as a potential determinant of poor prognosis in malignant glioma.Prog Lipid Res. 2013 Oct;52(4):562-70. doi: 10.1016/j.plipres.2013.08.004. Epub 2013 Aug 24.
|
| 158 |
Extraneural Metastases From a High-Grade Glioma (HGG) With an H3F3A G34R Mutation.Front Oncol. 2019 May 8;9:373. doi: 10.3389/fonc.2019.00373. eCollection 2019.
|
| 159 |
Neonatal exposure to estradiol/bisphenol A alters promoter methylation and expression of Nsbp1 and Hpcal1 genes and transcriptional programs of Dnmt3a/b and Mbd2/4 in the rat prostate gland throughout life.Endocrinology. 2012 Jan;153(1):42-55. doi: 10.1210/en.2011-1308. Epub 2011 Nov 22.
|
| 160 |
Expression and activity of l-isoaspartyl methyltransferase decrease in stage progression of human astrocytic tumors.Brain Res Mol Brain Res. 2005 Apr 27;135(1-2):93-103. doi: 10.1016/j.molbrainres.2004.12.008.
|
| 161 |
PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model.Clin Cancer Res. 2005 Aug 15;11(16):5965-70. doi: 10.1158/1078-0432.CCR-05-0371.
|
| 162 |
RTEL1: functions of a disease-associated helicase.Trends Cell Biol. 2014 Jul;24(7):416-25. doi: 10.1016/j.tcb.2014.01.004. Epub 2014 Feb 25.
|
| 163 |
ATDC contributes to sustaining the growth and invasion of glioma cells through regulating Wnt/-catenin signaling.Chem Biol Interact. 2019 May 25;305:148-155. doi: 10.1016/j.cbi.2019.03.033. Epub 2019 Mar 29.
|
| 164 |
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies. Nature. 2014 Oct 9;514(7521):247-51.
|
| 165 |
miR-141-3p functions as a tumor suppressor modulating activating transcription factor 5 in glioma.Biochem Biophys Res Commun. 2017 Sep 2;490(4):1260-1267. doi: 10.1016/j.bbrc.2017.05.179. Epub 2017 Jun 7.
|
| 166 |
A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications.Nat Med. 2010 Jun;16(6):671-7. doi: 10.1038/nm.2158. Epub 2010 May 23.
|
| 167 |
Modulation of TGF?activity by latent TGFbinding protein 1 in human osteoarthritis fibroblastlike synoviocytes.Mol Med Rep. 2018 Jan;17(1):1893-1900. doi: 10.3892/mmr.2017.8086. Epub 2017 Nov 15.
|
| 168 |
Human three prime exonuclease TREX1 is induced by genotoxic stress and involved in protection of glioma and melanoma cells to anticancer drugs. Biochim Biophys Acta. 2013 Aug;1833(8):1832-43. doi: 10.1016/j.bbamcr.2013.03.029. Epub 2013 Apr 8.
|
| 169 |
CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma.Oncogene. 2017 Sep 21;36(38):5356-5368. doi: 10.1038/onc.2017.145. Epub 2017 May 22.
|
| 170 |
The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus.Cancer Gene Ther. 2013 Aug;20(8):437-44. doi: 10.1038/cgt.2013.38. Epub 2013 Jul 5.
|
| 171 |
Expression of brain-specific angiogenesis inhibitor 3 (BAI3) in normal brain and implications for BAI3 in ischemia-induced brain angiogenesis and malignant glioma.FEBS Lett. 2004 Jul 2;569(1-3):307-16. doi: 10.1016/j.febslet.2004.06.011.
|
| 172 |
Novel report of expression and function of CD97 in malignant gliomas: correlation with Wilms tumor 1 expression and glioma cell invasiveness.J Neurosurg. 2012 Apr;116(4):843-53. doi: 10.3171/2011.11.JNS111455. Epub 2012 Feb 7.
|
| 173 |
Adherens junctional associated protein-1: a novel 1p36 tumor suppressor candidate in gliomas (Review).Int J Oncol. 2014 Jul;45(1):13-7. doi: 10.3892/ijo.2014.2425. Epub 2014 May 8.
|
| 174 |
ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma.Cell Death Dis. 2018 Dec 11;9(12):1190. doi: 10.1038/s41419-018-1232-3.
|
| 175 |
Up-regulation of ANKDR49, a poor prognostic factor, regulates cell proliferation of gliomas.Biosci Rep. 2017 Aug 4;37(4):BSR20170800. doi: 10.1042/BSR20170800. Print 2017 Aug 31.
|
| 176 |
AQP4 Aggregation State Is a Determinant for Glioma Cell Fate.Cancer Res. 2019 May 1;79(9):2182-2194. doi: 10.1158/0008-5472.CAN-18-2015. Epub 2019 Mar 15.
|
| 177 |
Regeneration and tolerance factor: a novel mediator of glioblastoma-associated immunosuppression.Cancer Res. 2006 Apr 1;66(7):3852-8. doi: 10.1158/0008-5472.CAN-05-3062.
|
| 178 |
DWI for Monitoring the Acute Response of Malignant Gliomas to Photodynamic Therapy.AJNR Am J Neuroradiol. 2019 Dec;40(12):2045-2051. doi: 10.3174/ajnr.A6300. Epub 2019 Nov 21.
|
| 179 |
pERK, pAkt and pBad: a possible role in cell proliferation and sustained cellular survival during tumorigenesis and tumor progression in ENU induced transplacental glioma rat model.Neurochem Res. 2006 Sep;31(9):1163-70. doi: 10.1007/s11064-006-9142-7. Epub 2006 Aug 31.
|
| 180 |
Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas.Cancer Res. 2005 Aug 1;65(15):6726-33. doi: 10.1158/0008-5472.CAN-05-0585.
|
| 181 |
Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma.Cancer Res. 2006 Jul 1;66(13):6665-74. doi: 10.1158/0008-5472.CAN-05-4453.
|
| 182 |
Mitochondrial dysfunction in gliomas.Semin Pediatr Neurol. 2013 Sep;20(3):216-27. doi: 10.1016/j.spen.2013.09.003.
|
| 183 |
Adenoviral natural born killer gene therapy for malignant glioma.Hum Gene Ther. 2003 Sep 1;14(13):1235-46. doi: 10.1089/104303403767740777.
|
| 184 |
Decreased BRMS1L expression is correlated with glioma grade and predicts poor survival in glioblastoma via an invasive phenotype.Cancer Biomark. 2018;22(2):311-316. doi: 10.3233/CBM-171019.
|
| 185 |
Expression of mRNAs of urocortin and corticotropin-releasing factor receptors in malignant glioma cell lines.Anticancer Res. 2012 Dec;32(12):5299-307.
|
| 186 |
Enhanced repair of a cisplatin-damaged reporter chloramphenicol-O-acetyltransferase gene and altered activities of DNA polymerases alpha and beta, and DNA ligase in cells of a human malignant glioma following in vivo cisplatin therapy.J Cell Biochem. 1994 Jan;54(1):11-9. doi: 10.1002/jcb.240540103.
|
| 187 |
Loss of merlin-p85 protein complex in NF2-related tumors.Int J Oncol. 1998 May;12(5):1073-8. doi: 10.3892/ijo.12.5.1073.
|
| 188 |
Procarbazine and CCNU Chemotherapy for Recurrent Glioblastoma with MGMT Promoter Methylation.J Korean Med Sci. 2018 May 10;33(24):e167. doi: 10.3346/jkms.2018.33.e167. eCollection 2018 Jun 11.
|
| 189 |
Revealing the glioma cancer stem cell interactome, one niche at a time.J Pathol. 2018 Mar;244(3):260-264. doi: 10.1002/path.5024. Epub 2018 Feb 2.
|
| 190 |
CD93 promotes 1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.J Clin Invest. 2018 Aug 1;128(8):3280-3297. doi: 10.1172/JCI97459. Epub 2018 Jun 25.
|
| 191 |
CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomas.EBioMedicine. 2018 Sep;35:233-243. doi: 10.1016/j.ebiom.2018.08.012. Epub 2018 Aug 18.
|
| 192 |
Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.J Neurol Sci. 2016 Apr 15;363:80-3. doi: 10.1016/j.jns.2016.02.032. Epub 2016 Feb 16.
|
| 193 |
CREB3L1 and PTN expressions correlate with prognosis of brain glioma patients.Biosci Rep. 2018 May 22;38(3):BSR20170100. doi: 10.1042/BSR20170100. Print 2018 May 29.
|
| 194 |
Localization patterns of cathepsins K and X and their predictive value in glioblastoma.Radiol Oncol. 2018 Oct 18;52(4):433-442. doi: 10.2478/raon-2018-0040.
|
| 195 |
Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant glioma.J Immunother. 2003 Jul-Aug;26(4):301-12. doi: 10.1097/00002371-200307000-00002.
|
| 196 |
DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis.Cancer Res. 2002 Mar 15;62(6):1790-6.
|
| 197 |
ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion.Cancer Res. 2007 Aug 1;67(15):7203-11. doi: 10.1158/0008-5472.CAN-07-0473.
|
| 198 |
Combining Diffusion Tensor Metrics and DSC Perfusion Imaging: Can It Improve the Diagnostic Accuracy in Differentiating Tumefactive Demyelination from High-Grade Glioma?.AJNR Am J Neuroradiol. 2017 Apr;38(4):685-690. doi: 10.3174/ajnr.A5089. Epub 2017 Feb 16.
|
| 199 |
ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma.BMC Cancer. 2009 Dec 17;9:447. doi: 10.1186/1471-2407-9-447.
|
| 200 |
Epithelial cell transformation sequence 2 is a potential biomarker of unfavorable survival in human gliomas.Neurol India. 2014 Jul-Aug;62(4):406-9. doi: 10.4103/0028-3886.141278.
|
| 201 |
Tumor-derived fibulin-3 activates pro-invasive NF-B signaling in glioblastoma cells and their microenvironment.Oncogene. 2017 Aug 24;36(34):4875-4886. doi: 10.1038/onc.2017.109. Epub 2017 Apr 17.
|
| 202 |
MGMT as a potential stratification marker in relapsed high-grade glioma of children: the HIT-GBM experience.Pediatr Blood Cancer. 2010 Feb;54(2):228-37. doi: 10.1002/pbc.22323.
|
| 203 |
hHSS1: a novel secreted factor and suppressor of glioma growth located at chromosome 19q13.33.J Neurooncol. 2011 Apr;102(2):197-211. doi: 10.1007/s11060-010-0314-6. Epub 2010 Jul 31.
|
| 204 |
Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.Oncol Rep. 2019 Aug;42(2):605-614. doi: 10.3892/or.2019.7204. Epub 2019 Jun 19.
|
| 205 |
Whole-Genome Expression Microarray Combined with Machine Learning to Identify Prognostic Biomarkers for High-Grade Glioma.J Mol Neurosci. 2018 Apr;64(4):491-500. doi: 10.1007/s12031-018-1049-7. Epub 2018 Mar 3.
|
| 206 |
Enolase-phosphatase 1 as a novel potential malignant glioma indicator promotes cell proliferation and migration.Oncol Rep. 2018 Oct;40(4):2233-2241. doi: 10.3892/or.2018.6592. Epub 2018 Jul 24.
|
| 207 |
Eps8 promotes cellular growth of human malignant gliomas.Oncol Rep. 2013 Feb;29(2):697-703. doi: 10.3892/or.2012.2160. Epub 2012 Nov 29.
|
| 208 |
A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter.Int J Oncol. 2001 Nov;19(5):1015-20. doi: 10.3892/ijo.19.5.1015.
|
| 209 |
Clinical significance of FBXO17 gene expression in high-grade glioma.BMC Cancer. 2018 Jul 31;18(1):773. doi: 10.1186/s12885-018-4680-3.
|
| 210 |
Decreased expression of germinal center-associated nuclear protein is involved in chromosomal instability in malignant gliomas.Cancer Sci. 2009 Nov;100(11):2069-76. doi: 10.1111/j.1349-7006.2009.01293.x. Epub 2009 Jul 21.
|
| 211 |
MiR-148a increases glioma cell migration and invasion by downregulating GADD45A in human gliomas with IDH1 R132H mutations.Oncotarget. 2017 Apr 11;8(15):25345-25361. doi: 10.18632/oncotarget.15867.
|
| 212 |
regulation of the invasion and metastasis of human glioma cells by polypeptide N-acetylgalactosaminyltransferase 2.Mol Med Rep. 2011 Nov-Dec;4(6):1299-305. doi: 10.3892/mmr.2011.569. Epub 2011 Aug 22.
|
| 213 |
miRNA-124-3p/neuropilin-1(NRP-1) axis plays an important role in mediating glioblastoma growth and angiogenesis.Int J Cancer. 2018 Aug 1;143(3):635-644. doi: 10.1002/ijc.31329. Epub 2018 Mar 2.
|
| 214 |
Differential expression of nucleostemin, a stem cell marker, and its variants in different types of brain tumors.Mol Carcinog. 2010 Sep;49(9):818-25. doi: 10.1002/mc.20658.
|
| 215 |
Golgi Phosphoprotein 3 Inhibits the Apoptosis of Human Glioma Cells in Part by Downregulating N-myc Downstream Regulated Gene 1.Med Sci Monit. 2016 Oct 4;22:3535-3543. doi: 10.12659/msm.900349.
|
| 216 |
The 10q25.3-26.1 G protein-coupled receptor gene GPR26 is epigenetically silenced in human gliomas.Int J Oncol. 2009 Nov;35(5):1123-31. doi: 10.3892/ijo_00000428.
|
| 217 |
Preferential expression of functional IL-17R in glioma stem cells: potential role in self-renewal.Oncotarget. 2016 Feb 2;7(5):6121-35. doi: 10.18632/oncotarget.6847.
|
| 218 |
ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro.Neuro Oncol. 2013 Aug;15(8):990-1007. doi: 10.1093/neuonc/not039. Epub 2013 Apr 10.
|
| 219 |
HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma.Oncol Rep. 2019 Dec;42(6):2309-2322. doi: 10.3892/or.2019.7343. Epub 2019 Oct 1.
|
| 220 |
Histidine-rich glycoprotein can prevent development of mouse experimental glioblastoma.PLoS One. 2009 Dec 31;4(12):e8536. doi: 10.1371/journal.pone.0008536.
|
| 221 |
Comparison of (18)F-GE-180 and dynamic (18)F-FET PET in high grade glioma: a double-tracer pilot study.Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):580-590. doi: 10.1007/s00259-018-4166-1. Epub 2018 Sep 22.
|
| 222 |
IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway.Oncotarget. 2017 Jul 25;8(30):49502-49514. doi: 10.18632/oncotarget.17738.
|
| 223 |
Tetraspanin 8-rictor-integrin 3 complex is required for glioma cell migration.Int J Mol Sci. 2015 Mar 9;16(3):5363-74. doi: 10.3390/ijms16035363.
|
| 224 |
Integrin 7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma.Cell Stem Cell. 2017 Jul 6;21(1):35-50.e9. doi: 10.1016/j.stem.2017.04.009. Epub 2017 Jun 9.
|
| 225 |
Epigenetic silencing of KAZALD1 confers a better prognosis and is associated with malignant transformation/progression in glioma.Oncol Rep. 2013 Nov;30(5):2089-96. doi: 10.3892/or.2013.2706. Epub 2013 Aug 29.
|
| 226 |
KIF23 is an independent prognostic biomarker in glioma, transcriptionally regulated by TCF-4.Oncotarget. 2016 Apr 26;7(17):24646-55. doi: 10.18632/oncotarget.8261.
|
| 227 |
Krppel-like factor 8 (KLF8) is expressed in gliomas of different WHO grades and is essential for tumor cell proliferation.PLoS One. 2012;7(1):e30429. doi: 10.1371/journal.pone.0030429. Epub 2012 Jan 19.
|
| 228 |
Neurosarcoidosis Mimics High-Grade Glioma in Dynamic 18F-FET PET Due to LAT Expression.Clin Nucl Med. 2018 Nov;43(11):840-841. doi: 10.1097/RLU.0000000000002266.
|
| 229 |
Layilin enhances the invasive ability of malignant glioma cells via SNAI1 signaling.Brain Res. 2019 Sep 15;1719:140-147. doi: 10.1016/j.brainres.2019.05.034. Epub 2019 May 27.
|
| 230 |
LGI1: a gene involved in epileptogenesis and glioma progression?.Neurogenetics. 2005 May;6(2):59-66. doi: 10.1007/s10048-005-0216-5. Epub 2005 Apr 13.
|
| 231 |
Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter.Cancer Res. 2007 Dec 15;67(24):11499-504. doi: 10.1158/0008-5472.CAN-07-5312.
|
| 232 |
Hugl-1 inhibits glioma cell growth in intracranial model.J Neurooncol. 2015 Oct;125(1):113-21. doi: 10.1007/s11060-015-1901-3. Epub 2015 Sep 4.
|
| 233 |
GAC1, a new member of the leucine-rich repeat superfamily on chromosome band 1q32.1, is amplified and overexpressed in malignant gliomas.Oncogene. 1998 Jun 11;16(23):2997-3002. doi: 10.1038/sj.onc.1201828.
|
| 234 |
Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.Neuro Oncol. 2013 Dec;15(12):1696-709. doi: 10.1093/neuonc/not136. Epub 2013 Nov 11.
|
| 235 |
Regulatory landscape and clinical implication of MBD3 in human malignant glioma.Oncotarget. 2016 Dec 6;7(49):81698-81714. doi: 10.18632/oncotarget.13173.
|
| 236 |
Myocyte enhancer factor 2D promotes tumorigenicity in malignant glioma cells.Tumour Biol. 2016 Jan;37(1):601-10. doi: 10.1007/s13277-015-3791-6. Epub 2015 Aug 4.
|
| 237 |
Epidermal growth factor receptor gene expression in high grade gliomas.Folia Neuropathol. 2011;49(1):28-38.
|
| 238 |
Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas.Neurosci Res. 2008 Jan;60(1):40-9. doi: 10.1016/j.neures.2007.09.009. Epub 2007 Sep 29.
|
| 239 |
Mannose phosphate isomerase regulates fibroblast growth factor receptor family signaling and glioma radiosensitivity. PLoS One. 2014 Oct 14;9(10):e110345.
|
| 240 |
miR-126 Suppresses Invasion and Migration of Malignant Glioma by Targeting Mature T Cell Proliferation 1 (MTCP1).Med Sci Monit. 2018 Sep 20;24:6630-6637. doi: 10.12659/MSM.910292.
|
| 241 |
Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma.Nature. 2017 Sep 28;549(7673):533-537. doi: 10.1038/nature24014. Epub 2017 Sep 20.
|
| 242 |
MicroRNA-326 functions as a tumor suppressor in glioma by targeting the Nin one binding protein (NOB1).PLoS One. 2013 Jul 15;8(7):e68469. doi: 10.1371/journal.pone.0068469. Print 2013.
|
| 243 |
DNA content and chromosomal composition of malignant human gliomas.Neurol Clin. 1985 Nov;3(4):769-84.
|
| 244 |
NPAS3 demonstrates features of a tumor suppressive role in driving the progression of Astrocytomas.Am J Pathol. 2011 Jul;179(1):462-76. doi: 10.1016/j.ajpath.2011.03.044. Epub 2011 May 19.
|
| 245 |
Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.Oncogene. 2019 May;38(21):4154-4168. doi: 10.1038/s41388-019-0714-9. Epub 2019 Jan 31.
|
| 246 |
NUMB does not impair growth and differentiation status of experimental gliomas.Exp Cell Res. 2011 Dec 10;317(20):2864-73. doi: 10.1016/j.yexcr.2011.09.002. Epub 2011 Sep 12.
|
| 247 |
Harnessing OLIG2 function in tumorigenicity and plasticity to target malignant gliomas.Cell Cycle. 2017 Sep 17;16(18):1654-1660. doi: 10.1080/15384101.2017.1361062. Epub 2017 Aug 14.
|
| 248 |
Interplay between PCBP2 and miRNA modulates ARHGDIA expression and function in glioma migration and invasion.Oncotarget. 2016 Apr 12;7(15):19483-98. doi: 10.18632/oncotarget.6869.
|
| 249 |
Dual inhibition of PCDH9 expression by miR-215-5p up-regulation in gliomas.Oncotarget. 2017 Feb 7;8(6):10287-10297. doi: 10.18632/oncotarget.14396.
|
| 250 |
NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma.Oncogene. 2017 Aug 17;36(33):4706-4718. doi: 10.1038/onc.2017.34. Epub 2017 Apr 10.
|
| 251 |
PDCD5 promotes cisplatin-induced apoptosis of glioma cells via activating mitochondrial apoptotic pathway.Cancer Biol Ther. 2012 Jul;13(9):822-30. doi: 10.4161/cbt.20565. Epub 2012 Jun 12.
|
| 252 |
Integrin 51 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma.Cell Death Differ. 2016 Apr;23(4):640-53. doi: 10.1038/cdd.2015.131. Epub 2015 Oct 16.
|
| 253 |
Prediction of relapse and prognosis by expression levels of long noncoding RNA PEG10 in glioma patients.Medicine (Baltimore). 2019 Nov;98(45):e17583. doi: 10.1097/MD.0000000000017583.
|
| 254 |
PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas.Clin Cancer Res. 2014 Feb 15;20(4):827-36. doi: 10.1158/1078-0432.CCR-13-2053. Epub 2013 Dec 3.
|
| 255 |
Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells.Cell Physiol Biochem. 1999;9(3):117-25. doi: 10.1159/000016308.
|
| 256 |
Subcellular distribution and expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in malignant glioma: Influence on cell survival and migration.Cancer Sci. 2010 Jul;101(7):1624-31. doi: 10.1111/j.1349-7006.2010.01570.x. Epub 2010 Mar 19.
|
| 257 |
Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas.Arch Pathol Lab Med. 2017 Dec;141(12):1697-1704. doi: 10.5858/arpa.2016-0580-OA. Epub 2017 Aug 22.
|
| 258 |
Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma.CNS Neurosci Ther. 2017 Jan;23(1):69-75. doi: 10.1111/cns.12606. Epub 2016 Sep 17.
|
| 259 |
Structural Insights into the Quaternary Catalytic Mechanism of Hexameric Human Quinolinate Phosphoribosyltransferase, a Key Enzyme in de novo NAD Biosynthesis.Sci Rep. 2016 Jan 25;6:19681. doi: 10.1038/srep19681.
|
| 260 |
Hypomethylated Rab27b is a progression-associated prognostic biomarker of glioma regulating MMP-9 to promote invasion.Oncol Rep. 2015 Sep;34(3):1503-9. doi: 10.3892/or.2015.4125. Epub 2015 Jul 13.
|
| 261 |
DNA hypermethylation and histone modifications downregulate the candidate tumor suppressor gene RRP22 on 22q12 in human gliomas.Brain Pathol. 2012 Jan;22(1):17-25. doi: 10.1111/j.1750-3639.2011.00507.x. Epub 2011 Aug 16.
|
| 262 |
RHPN2 drives mesenchymal transformation in malignant glioma by triggering RhoA activation.Cancer Res. 2013 Aug 15;73(16):5140-50. doi: 10.1158/0008-5472.CAN-13-1168-T. Epub 2013 Jun 17.
|
| 263 |
Inference of Low and High-Grade Glioma Gene Regulatory Networks Delineates the Role of Rnd3 in Establishing Multiple Hallmarks of Cancer.PLoS Genet. 2015 Jul 1;11(7):e1005325. doi: 10.1371/journal.pgen.1005325. eCollection 2015 Jul.
|
| 264 |
SAMSN1 is highly expressed and associated with a poor survival in glioblastoma multiforme.PLoS One. 2013 Nov 22;8(11):e81905. doi: 10.1371/journal.pone.0081905. eCollection 2013.
|
| 265 |
Ubiquitin ligase Siah1 promotes the migration and invasion of human glioma cells by regulating HIF-1 signaling under hypoxia.Oncol Rep. 2015 Mar;33(3):1185-90. doi: 10.3892/or.2014.3695. Epub 2014 Dec 23.
|
| 266 |
Sox11 expression in astrocytic gliomas: correlation with nestin/c-Met/IDH1-R132H expression phenotypes, p-Stat-3 and survival.Br J Cancer. 2013 May 28;108(10):2142-52. doi: 10.1038/bjc.2013.176. Epub 2013 Apr 25.
|
| 267 |
Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormality.J Exp Med. 2018 Mar 5;215(3):963-983. doi: 10.1084/jem.20170123. Epub 2018 Feb 14.
|
| 268 |
Alpha2,6-sialylation of cell-surface N-glycans inhibits glioma formation in vivo.Cancer Res. 2001 Sep 15;61(18):6822-9.
|
| 269 |
Tax-interacting protein 1 coordinates the spatiotemporal activation of Rho GTPases and regulates the infiltrative growth of human glioblastoma.Oncogene. 2014 Mar 20;33(12):1558-69. doi: 10.1038/onc.2013.97. Epub 2013 Apr 8.
|
| 270 |
Integrin 6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells.Oncogene. 2020 Mar;39(10):2156-2169. doi: 10.1038/s41388-019-1134-6. Epub 2019 Dec 9.
|
| 271 |
Characterization and transduction of a retroviral vector encoding human interleukin-4 and herpes simplex virus-thymidine kinase for glioma tumor vaccine therapy.Cancer Gene Ther. 2000 Mar;7(3):486-94. doi: 10.1038/sj.cgt.7700140.
|
| 272 |
Knockdown of TFPI-2 promotes migration and invasion of glioma cells.Neurosci Lett. 2011 Jun 15;497(1):49-54. doi: 10.1016/j.neulet.2011.04.027. Epub 2011 Apr 20.
|
| 273 |
Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.Neuro Oncol. 2017 May 1;19(5):660-668. doi: 10.1093/neuonc/now239.
|
| 274 |
microRNA response elementregulated TIKI2 expression suppresses the tumorigencity of malignant gliomas.Mol Med Rep. 2014 Oct;10(4):2079-86. doi: 10.3892/mmr.2014.2412. Epub 2014 Jul 22.
|
| 275 |
miR-29s function as tumor suppressors in gliomas by targeting TRAF4 and predict patient prognosis.Cell Death Dis. 2018 Oct 22;9(11):1078. doi: 10.1038/s41419-018-1092-x.
|
| 276 |
Expression of TRAP1 predicts poor survival of malignant glioma patients.J Mol Neurosci. 2015 Jan;55(1):62-68. doi: 10.1007/s12031-014-0413-5. Epub 2014 Sep 5.
|
| 277 |
TRIM11, a direct target of miR-24-3p, promotes cell proliferation and inhibits apoptosis in colon cancer.Oncotarget. 2016 Dec 27;7(52):86755-86765. doi: 10.18632/oncotarget.13550.
|
| 278 |
Overexpression of the orphan receptor Nur77 and its translocation induced by PCH4 may inhibit malignant glioma cell growth and induce cell apoptosis.J Surg Oncol. 2011 Apr;103(5):442-50. doi: 10.1002/jso.21809. Epub 2011 Jan 18.
|
| 279 |
Over-expression of tetraspanin 8 in malignant glioma regulates tumor cell progression.Biochem Biophys Res Commun. 2015 Mar 13;458(3):476-482. doi: 10.1016/j.bbrc.2015.01.128. Epub 2015 Feb 11.
|
| 280 |
Construction of a ganciclovir-sensitive lentiviral vector to assess the influence of angiopoietin-3 and soluble Tie2 on glioma growth.J Neurooncol. 2010 Aug;99(1):1-11. doi: 10.1007/s11060-009-0095-y. Epub 2009 Dec 18.
|
| 281 |
Aberrant methylation and reduced expression of LHX9 in malignant gliomas of childhood.Neoplasia. 2009 Jul;11(7):700-11. doi: 10.1593/neo.09406.
|
| 282 |
Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma.Oncogenesis. 2018 Feb 2;7(2):13. doi: 10.1038/s41389-017-0012-8.
|
| 283 |
Expression analysis of the autosomal recessive primary microcephaly genes MCPH1 (microcephalin) and MCPH5 (ASPM, abnormal spindle-like, microcephaly associated) in human malignant gliomas.Oncol Rep. 2008 Aug;20(2):301-8.
|
|
|
|
|
|
|
